May 17: GA101 succeeds in Phase III
May 16: BASF broadens enzyme business
May 15: EU fuels synthetic biology
May 14: Cosmo places Santarus shares
May 13: Novartis gets FDA ok for Ilaris
May 10: Stem cell experts raise €19m
May 08: Ablynx targets allergic asthma
May 07: STAT-Diagnostica closes €17m round
May 06: Sanofi licences mAbs programmes
May 03: EMA may not publish trial data
May 02: FDA greenlights Roche's Actemra
Apr 30: Heptares bags Takeda milestones
Apr 29: Turn bad into good fat
Apr 26: Genticel bags €18.2m
Apr 25: BIO: debating value in Chicago
Apr 24: Bayer partners with KeyGene
Apr 23: Horizon teams up with AstraZeneca
Apr 22: Diagnosis: computer beats doctor
Apr 19: Allecra kicks off with €15m
Apr 18: Sofinnova puts €42m into Auris
Apr 17: BMS enters deal with Santharis
Apr 16: Biotechs snap up EU money
Apr 15: Carbios inks €7m collaboration
Apr 12: Sanofi ramps up artemisinin plant
Apr 11: Six partners seek kinase drugs
Apr 10: Trial success for Lundbeck
Apr 09: Gene therapy enters the eye
Apr 07: AstraZeneca fails endpoint
Apr 05: Blood test for prostate cancer
Apr 04: A fingerprint of exhaled breath
